The effects of fluoxetine, which is a selective inhibitor of serotonin reup
take (SSRI) have been studied on the intraocular pressure (IOP) in the rabb
it. IOP was measured using a Perkins tonometer. Intravenous administration
of fluoxetine (6.0 mg kg(-1)) significantly increased IOP by 7.2 +/- 1.3 mm
Hg (P < 0.001). Fluoxetine administration also reduced the amount of urine
excreted during the 24 hr, and increased the urine concentration of 5-hydro
xyindole acetic acid (5-HIAA). Topical preadministration of ketanserin prev
ented a rise in IOP, without there being any effects on the other parameter
s examined.
These findings indicate that intravenous administration of fluoxetine is ab
le to raise IOP, through increased plasma levels of serotonin, which is con
firmed by elevated 5-HIAA urine excretion and reduction in diuresis. Ketans
erin, a specific 5-HT2A antagonist, counteracts the IOP increase brought ab
out by fluoxetine, thus emphasizing the role of serotonin in the regulation
of IOP and stressing the importance of including ophthalmological examinat
ion in the protocol of depressed patients undergoing SSRI therapy. (C) 2000
Academic Press.